Cargando…

E-Cadherin Expression Is Regulated by miR-192/215 by a Mechanism That Is Independent of the Profibrotic Effects of Transforming Growth Factor-β

OBJECTIVE: Increased deposition of extracellular matrix (ECM) within the kidney is driven by profibrotic mediators including transforming growth factor-β (TGF-β) and connective tissue growth factor (CTGF). We investigated whether some of their effects may be mediated through changes in expression of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bo, Herman-Edelstein, Michal, Koh, Philip, Burns, Wendy, Jandeleit-Dahm, Karin, Watson, Anna, Saleem, Moin, Goodall, Gregory J., Twigg, Stephen M., Cooper, Mark E., Kantharidis, Phillip
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889781/
https://www.ncbi.nlm.nih.gov/pubmed/20393144
http://dx.doi.org/10.2337/db09-1736
_version_ 1782182714045104128
author Wang, Bo
Herman-Edelstein, Michal
Koh, Philip
Burns, Wendy
Jandeleit-Dahm, Karin
Watson, Anna
Saleem, Moin
Goodall, Gregory J.
Twigg, Stephen M.
Cooper, Mark E.
Kantharidis, Phillip
author_facet Wang, Bo
Herman-Edelstein, Michal
Koh, Philip
Burns, Wendy
Jandeleit-Dahm, Karin
Watson, Anna
Saleem, Moin
Goodall, Gregory J.
Twigg, Stephen M.
Cooper, Mark E.
Kantharidis, Phillip
author_sort Wang, Bo
collection PubMed
description OBJECTIVE: Increased deposition of extracellular matrix (ECM) within the kidney is driven by profibrotic mediators including transforming growth factor-β (TGF-β) and connective tissue growth factor (CTGF). We investigated whether some of their effects may be mediated through changes in expression of certain microRNAs (miRNAs). RESEARCH DESIGN AND METHODS: Proximal tubular cells, primary rat mesangial cells, and human podocytes were analyzed for changes in the expression of key genes, ECM proteins, and miRNA after exposure to TGF-β (1–10 ng/μl). Tubular cells were also infected with CTGF-adenovirus. Kidneys from diabetic apoE mice were also analyzed for changes in gene expression and miRNA levels. RESULTS: TGF-β treatment was associated with morphologic and phenotypic changes typical of epithelial-mesenchymal transition (EMT) including increased fibrogenesis in all renal cell types and decreased E-cadherin expression in tubular cells. TGF-β treatment also modulated the expression of certain miRNAs, including decreased expression of miR-192/215 in tubular cells, mesangial cells, which are also decreased in diabetic kidney. Ectopic expression of miR-192/215 increased E-cadherin levels via repressed translation of ZEB2 mRNA, in the presence and absence of TGF-β, as demonstrated by a ZEB2 3′-untranslated region luciferase reporter assay. However, ectopic expression of miR-192/215 did not affect the expression of matrix proteins or their induction by TGF-β. In contrast, CTGF increased miR-192/215 levels, causing a decrease in ZEB2, and consequently increased E-cadherin mRNA. CONCLUSIONS: These data demonstrate the linking role of miRNA-192/215 and ZEB2 in TGF-β/CTGF–mediated changes in E-cadherin expression. These changes appear to occur independently of augmentation of matrix protein synthesis, suggesting that a multistep EMT program is not necessary for fibrogenesis to occur.
format Text
id pubmed-2889781
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-28897812011-07-01 E-Cadherin Expression Is Regulated by miR-192/215 by a Mechanism That Is Independent of the Profibrotic Effects of Transforming Growth Factor-β Wang, Bo Herman-Edelstein, Michal Koh, Philip Burns, Wendy Jandeleit-Dahm, Karin Watson, Anna Saleem, Moin Goodall, Gregory J. Twigg, Stephen M. Cooper, Mark E. Kantharidis, Phillip Diabetes Complications OBJECTIVE: Increased deposition of extracellular matrix (ECM) within the kidney is driven by profibrotic mediators including transforming growth factor-β (TGF-β) and connective tissue growth factor (CTGF). We investigated whether some of their effects may be mediated through changes in expression of certain microRNAs (miRNAs). RESEARCH DESIGN AND METHODS: Proximal tubular cells, primary rat mesangial cells, and human podocytes were analyzed for changes in the expression of key genes, ECM proteins, and miRNA after exposure to TGF-β (1–10 ng/μl). Tubular cells were also infected with CTGF-adenovirus. Kidneys from diabetic apoE mice were also analyzed for changes in gene expression and miRNA levels. RESULTS: TGF-β treatment was associated with morphologic and phenotypic changes typical of epithelial-mesenchymal transition (EMT) including increased fibrogenesis in all renal cell types and decreased E-cadherin expression in tubular cells. TGF-β treatment also modulated the expression of certain miRNAs, including decreased expression of miR-192/215 in tubular cells, mesangial cells, which are also decreased in diabetic kidney. Ectopic expression of miR-192/215 increased E-cadherin levels via repressed translation of ZEB2 mRNA, in the presence and absence of TGF-β, as demonstrated by a ZEB2 3′-untranslated region luciferase reporter assay. However, ectopic expression of miR-192/215 did not affect the expression of matrix proteins or their induction by TGF-β. In contrast, CTGF increased miR-192/215 levels, causing a decrease in ZEB2, and consequently increased E-cadherin mRNA. CONCLUSIONS: These data demonstrate the linking role of miRNA-192/215 and ZEB2 in TGF-β/CTGF–mediated changes in E-cadherin expression. These changes appear to occur independently of augmentation of matrix protein synthesis, suggesting that a multistep EMT program is not necessary for fibrogenesis to occur. American Diabetes Association 2010-07 2010-04-14 /pmc/articles/PMC2889781/ /pubmed/20393144 http://dx.doi.org/10.2337/db09-1736 Text en © 2010 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Complications
Wang, Bo
Herman-Edelstein, Michal
Koh, Philip
Burns, Wendy
Jandeleit-Dahm, Karin
Watson, Anna
Saleem, Moin
Goodall, Gregory J.
Twigg, Stephen M.
Cooper, Mark E.
Kantharidis, Phillip
E-Cadherin Expression Is Regulated by miR-192/215 by a Mechanism That Is Independent of the Profibrotic Effects of Transforming Growth Factor-β
title E-Cadherin Expression Is Regulated by miR-192/215 by a Mechanism That Is Independent of the Profibrotic Effects of Transforming Growth Factor-β
title_full E-Cadherin Expression Is Regulated by miR-192/215 by a Mechanism That Is Independent of the Profibrotic Effects of Transforming Growth Factor-β
title_fullStr E-Cadherin Expression Is Regulated by miR-192/215 by a Mechanism That Is Independent of the Profibrotic Effects of Transforming Growth Factor-β
title_full_unstemmed E-Cadherin Expression Is Regulated by miR-192/215 by a Mechanism That Is Independent of the Profibrotic Effects of Transforming Growth Factor-β
title_short E-Cadherin Expression Is Regulated by miR-192/215 by a Mechanism That Is Independent of the Profibrotic Effects of Transforming Growth Factor-β
title_sort e-cadherin expression is regulated by mir-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-β
topic Complications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889781/
https://www.ncbi.nlm.nih.gov/pubmed/20393144
http://dx.doi.org/10.2337/db09-1736
work_keys_str_mv AT wangbo ecadherinexpressionisregulatedbymir192215byamechanismthatisindependentoftheprofibroticeffectsoftransforminggrowthfactorb
AT hermanedelsteinmichal ecadherinexpressionisregulatedbymir192215byamechanismthatisindependentoftheprofibroticeffectsoftransforminggrowthfactorb
AT kohphilip ecadherinexpressionisregulatedbymir192215byamechanismthatisindependentoftheprofibroticeffectsoftransforminggrowthfactorb
AT burnswendy ecadherinexpressionisregulatedbymir192215byamechanismthatisindependentoftheprofibroticeffectsoftransforminggrowthfactorb
AT jandeleitdahmkarin ecadherinexpressionisregulatedbymir192215byamechanismthatisindependentoftheprofibroticeffectsoftransforminggrowthfactorb
AT watsonanna ecadherinexpressionisregulatedbymir192215byamechanismthatisindependentoftheprofibroticeffectsoftransforminggrowthfactorb
AT saleemmoin ecadherinexpressionisregulatedbymir192215byamechanismthatisindependentoftheprofibroticeffectsoftransforminggrowthfactorb
AT goodallgregoryj ecadherinexpressionisregulatedbymir192215byamechanismthatisindependentoftheprofibroticeffectsoftransforminggrowthfactorb
AT twiggstephenm ecadherinexpressionisregulatedbymir192215byamechanismthatisindependentoftheprofibroticeffectsoftransforminggrowthfactorb
AT coopermarke ecadherinexpressionisregulatedbymir192215byamechanismthatisindependentoftheprofibroticeffectsoftransforminggrowthfactorb
AT kantharidisphillip ecadherinexpressionisregulatedbymir192215byamechanismthatisindependentoftheprofibroticeffectsoftransforminggrowthfactorb